Exploring demands of hemodialysis patients in Taiwan: A two-step cluster analysis

Yu, I-Chen; Fang, Ji‐Tseng; Tsai, Yun‐Fang

doi:10.1371/journal.pone.0228259

Cited by 4 publications

(3 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study from Malaysia found that dialysis patients having religion was associated with lower depression scores [44]. A positive correlation between hope and religious beliefs was found in patients undergoing haemodialysis; in that study, 97% of patients attributed their hope to religious beliefs [45 ▪ ].…”

Section: Related Risk Factorsmentioning

confidence: 80%

Depression in dialysis

Tian

Chen

2021

Current Opinion in Nephrology &Amp; Hypertension

View full text Add to dashboard Cite

Purpose of review The aim of this study was to examine updated prevalence rates, risk factors and the prognosis, diagnosis and treatments for depression among dialysis patients. Recent findings Depression influences prognosis, complications, quality of life (QOL), treatment and costs for dialysis patients worldwide. Reported prevalence of depression is 13.1–76.3%; it is higher for dialysis than transplant and higher post than predialysis. Reported depression rates with peritoneal dialysis (PD) compared with in-centre haemodialysis (HD) are inconsistent. Related medical factors are known, but suspected associated patient characteristics including gender and race remain unexplored. Associations between depression in dialysis and QOL, mortality, pathophysiological mechanisms of increased mortality, infection and pathways of inflammation-mediated and psychosocial factors require clarification. Several depression screening instruments are validated for dialysis patients – the Structured Clinical Interview for DSM disorders (SCID) remains the gold standard – but authors suggest the diagnostic standard should be higher than for the general population. Short-term studies indicate nonpharmacological therapy achieves clinical effects for depression in dialysis patients, but research on long-term effects is needed. Summary Depression management through early screening and continuous care models emphasizing dynamic relationships between healthcare teams, patients and families should be encouraged. Large-scale studies of short-term and long-term benefits of pharmacological and nonpharmacological depression management are warranted.

show abstract

Section: Related Risk Factorsmentioning

confidence: 80%

Depression in dialysis

Tian

Chen

2021

Current Opinion in Nephrology &Amp; Hypertension

View full text Add to dashboard Cite

show abstract

“…This finding may be due to Taiwan having a National Health Insurance scheme that subsidizes patients with major illnesses, injuries, and disabilities. These measures affect patients’ financial status and dialysis compliance, which are associated with healthcare insurance and social welfare, as suggested by previous studies [ 74 , 75 , 76 , 77 , 78 ]. In addition, Taiwanese HD patients’ five-year cumulative survival was 54.2% from 2009 to 2013, higher than that of American patients in 2012 (41.4%) and Canadian patients in 2011 (41.8%; 2020 Taiwan Society of Nephrology Annual Report).…”

Section: Discussionmentioning

confidence: 92%

Factors Related to Quality of Life of Hemodialysis Patients during the COVID-19 Pandemic

et al. 2023

View full text Add to dashboard Cite

Taiwan had the second highest number globally of end-stage renal disease patients undergoing treatment in 2018. A meta-analysis of Chen et al. (2021) showed the incidence and mortality rates of COVID-19 were 7.7% and 22.4%, respectively. Few studies have explored the effects of patients’ self-participation and perceptions of hemodialysis on their quality of life. This study aimed to explore the factors related to hemodialysis patients’ quality of life during the COVID-19 pandemic. This study was a descriptive correlational study. Patients were recruited (n = 298) from the hemodialysis unit of a medical center in northern Taiwan. Variables included patients’ sociodemographic, psychological, spiritual, and clinical characteristics (i.e., perceived health level, comorbidities, hemodialysis duration, weekly frequency, transportation, and accompaniment during hemodialysis), perceptions of hemodialysis, self-participation in hemodialysis, and health-related quality of life (KDQOL-36 scale). Data were analyzed using descriptive and bivariate and multivariate linear regression. Multivariate linear regression, after adjusting for covariates, showed that anxiety, self-perceived health status, two vs. four comorbidities, and self-participation in hemodialysis were significantly associated with quality of life. The overall model was significant and accounted for 52.2% (R2 = 0.522) of the variance in quality of life during hemodialysis (adjusted R2 = 0.480). In conclusion, the quality of life of hemodialysis patients with mild, moderate, or severe anxiety was poorer, whereas that of patients with fewer comorbidities, higher self-perceived health status, and higher self-participation in hemodialysis was better.

show abstract

“…RRTs include kidney transplantation and dialysis, of which hemodialysis (HD) is the most common form of intervention in most countries. In 2015 alone, 83,808 patients in Taiwan received dialysis treatment [ 1 ]. However, patients on dialysis have an increased risk of malignancy [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

The Effect of Statins in Cancer Risk Reduction in Patients on Dialysis: A Population-Based Case-Control Study

Chen

Jhou

Chung

et al. 2021

JCM

View full text Add to dashboard Cite

Background: To realize whether statins reduce the risk of cancer in susceptible dialysis populations, this study analyzed the relationship between statin use and cancer risk in patients on dialysis. Methods: Patients having a history of chronic kidney disease with hemodialysis or peritoneal dialysis and receiving statin prescriptions or not were enrolled. The main outcome was cancer diagnosis. This study used univariate and multivariate Cox regression analyses. Results: In total, 4236 individuals in the statin group and 8472 individuals in the statin nonuser group were included in the study. Multivariate Cox regression analysis revealed that statin users are significantly less likely to develop cancer than statin nonusers (adjusted hazard ratio (HR) 0.81, 95% confidence interval (CI) 0.78–0.90). Subgroup analyses revealed that statin cumulative defined daily doses >365 were associated with a significantly decreased risk of cancer incidence (adjusted HR 0.59, 95% CI 0.45–0.87), and statin users have a reduced risk of respiratory, soft tissue and connective tissue, breast, gynecological, prostate, central nervous system, and lymphatic and hematopoietic cancer than nonusers. Conclusions: Our population-based cohort study provides an association that statins reduce the risk of malignancy in patients on dialysis, especially with a longer treatment duration, and certain types of cancer.

show abstract

Exploring demands of hemodialysis patients in Taiwan: A two-step cluster analysis

Abstract: Aims and objectivesTo classify hemodialysis patients into subgroups via cluster analysis according to the Somatic Symptoms Disturbance Index, Taiwanese Depression Scale, and Herth Hope Index scores. Patient demands in each cluster were also examined.

Cited by 4 publications

References 30 publications

Depression in dialysis

Depression in dialysis

Factors Related to Quality of Life of Hemodialysis Patients during the COVID-19 Pandemic

The Effect of Statins in Cancer Risk Reduction in Patients on Dialysis: A Population-Based Case-Control Study

Contact Info

Product

Resources

About